Max Robert Ray Ii is a Lancaster, Ohio based psychologist who is specialized in Addiction (Substance Use Disorder) Psychology. His current practice location is 401 N Ewing St, Lancaster. Patients can reach him at 740-687-8040 or can fax him at 740-687-8965. Max Robert Ray Ii is LCDC III in Addiction (Substance Use Disorder) Psychology and his NPI number (Unique professional ID assigned by NPPES) is 1932609211. Max Robert Ray Ii help patients to develop ways to cope with their drug cravings. Also, he can suggest strategies to avoid drugs and prevent relapse, and can offer suggestions on how to deal with a relapse if it occurs. He make patients more aware of their feelings, thoughts and teach them different ways to deal with their problems.
Complete Profile:
Max Robert Ray Ii speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Max Robert Ray Ii
Specialization:
Addiction (Substance Use Disorder) Psychology
Gender:
Male
Credentials:
LCDC III
Practice Address:
401 N Ewing St, Lancaster, Ohio, 43130-3372
Phone:
740-687-8040
Fax:
740-687-8965
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1932609211
NPI Enumeration Date:
13 Feb, 2018
NPI Last Update On:
13 Feb, 2018
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Max Robert Ray Ii 401 N Ewing St, Lancaster, Ohio
Zip:
43130-3372
Phone Number:
740-687-8040
Fax Number:
740-687-8104
Patients can reach Max Robert Ray Ii at 401 N Ewing St, Lancaster, Ohio or can call to book an appointment on 740-687-8040.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.